These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33529007)

  • 21. Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First
    De La Vega JC; Esquinas PL; Rodríguez-Rodríguez C; Bokharaei M; Moskalev I; Liu D; Saatchi K; Häfeli UO
    Theranostics; 2019; 9(3):868-883. PubMed ID: 30809314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Salem R; Lewandowski RJ
    Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective study of Lipiodol distribution as an imaging marker for doxorubicin pharmacokinetics during conventional transarterial chemoembolization of liver malignancies.
    Savic LJ; Chapiro J; Funai E; Bousabarah K; Schobert IT; Isufi E; Geschwind JH; Stark S; He P; Rudek MA; Perez Lozada JC; Ayyagari R; Pollak J; Schlachter T
    Eur Radiol; 2021 May; 31(5):3002-3014. PubMed ID: 33063185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of Blood Pressure Changes in the Vascular Compartment When Using an Anti-Reflux Catheter during Chemoembolization versus Radioembolization: A Retrospective Case Series.
    Rose SC; Narsinh KH; Newton IG
    J Vasc Interv Radiol; 2017 Jan; 28(1):103-110. PubMed ID: 27840042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
    Wu B; Zhou J; Ling G; Zhu D; Long Q
    World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
    Fidelman N; Kerlan RK
    AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transarterial therapies for hepatocellular carcinoma.
    Sangro B; D'Avola D; Iñarrairaegui M; Prieto J
    Expert Opin Pharmacother; 2011 May; 12(7):1057-73. PubMed ID: 21470073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinoma.
    Liu YS; Ou MC; Tsai YS; Lin XZ; Wang CK; Tsai HM; Chuang MT
    Korean J Radiol; 2015; 16(1):125-32. PubMed ID: 25598680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioembolization for the treatment of hepatocellular carcinoma.
    Kim HC
    Clin Mol Hepatol; 2017 Jun; 23(2):109-114. PubMed ID: 28494530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment.
    Reiner CS; Gordic S; Puippe G; Morsbach F; Wurnig M; Schaefer N; Veit-Haibach P; Pfammatter T; Alkadhi H
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):400-8. PubMed ID: 26216725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of doxorubicin loading on response and toxicity with drug-eluting embolization in resectable hepatoma: a dose escalation study.
    Klass D; Owen D; Buczkowski A; Chung SW; Scudamore CH; Weiss AA; Yoshida EM; Ford JA; Ho S; Liu DM
    Anticancer Res; 2014 Jul; 34(7):3597-606. PubMed ID: 24982375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
    Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM
    Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-Eluting Porous Embolic Microspheres for Trans-Arterial Delivery of Dual Synergistic Anticancer Therapy for the Treatment of Liver Cancer.
    Amoyav B; Bloom AI; Goldstein Y; Miller R; Sharam M; Fluksman A; Benny O
    Adv Healthc Mater; 2023 Dec; 12(30):e2301548. PubMed ID: 37315950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response.
    Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X
    Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of Radioembolization in Treatment of Hepatocellular Carcinoma: A Pictorial Review.
    Miller FH; Lopes Vendrami C; Gabr A; Horowitz JM; Kelahan LC; Riaz A; Salem R; Lewandowski RJ
    Radiographics; 2021 Oct; 41(6):1802-1818. PubMed ID: 34559587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art.
    Facciorusso A
    World J Gastroenterol; 2018 Jan; 24(2):161-169. PubMed ID: 29375202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Hepatocellular Carcinoma with Tumor Thrombus with the Use of Iodine-125 Seed Strand Implantation and Transarterial Chemoembolization: A Propensity-Score Analysis.
    Zhang ZH; Zhang W; Gu JY; Liu QX; Ma JQ; Liu LX; Wang JH; Luo JJ; Yan ZP
    J Vasc Interv Radiol; 2018 Aug; 29(8):1085-1093. PubMed ID: 29754851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transarterial Chemoembolization Using 100-μm Drug-Eluting Microspheres in Patients with Hepatocellular Carcinoma: A Prospective Study and Midterm Follow-up.
    Ou HY; Wu YN; Yu CY; Chen CL; Hsu HW; Weng CC; Leung-Chit Tsang L; Huang TL; Tong YS; Lim WX; Cheng YF
    J Vasc Interv Radiol; 2020 Nov; 31(11):1784-1791. PubMed ID: 33023805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma.
    Chen M; Shu G; Lv X; Xu X; Lu C; Qiao E; Fang S; Shen L; Zhang N; Wang J; Chen C; Song J; Liu Z; Du Y; Ji J
    Biomaterials; 2022 May; 284():121512. PubMed ID: 35405577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of three transarterial lipiodol-based formulations for hepatocellular carcinoma: in vivo biodistribution study in humans.
    Yu SC; Leung TW; Lau WY; Lee N; Hui EP; Yeo W; Lai PB; Mok TS
    Cardiovasc Intervent Radiol; 2008; 31(2):289-98. PubMed ID: 17926090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.